Cardiac CT's continued rise | Is corporate ownership bad for patient care? | New TAVR guidewire impresses cardiologists

CCTA has seen rapid adoption and growth over the past two years, and RSNA vendors fed that trend with new product launches.

How do changes in ownership impact patient care? That was one of the many topics explored in a new survey of U.S. physicians.

The company behind the new technology was recently acquired for approximately $253 million. 

New AFib recommendations from the American College of Cardiology and American Heart Association covered significant ground—but there is still much more to learn, experts explained. 

Roche, one of the world’s largest pharmaceutical companies, will gain both oral and injectable assets as a result of this acquisition.

This is the second time in a matter of weeks the FDA has approved an RDN system for uncontrolled hypertension. The SCAI issued a statement about this trend, calling it a “game-changer for both interventional cardiology and the treatment of hypertension."

While the therapy has been successfully tested on animals in the past, this study represents the first time it has been used on humans.

The new technology, trained using more than 3 billion data points, was designed to reduce image noise and improve the overall quality of CT scans. 

The two giants in their respective industries plan to debut the first “MammogramNow” clinic Dec. 8 at the supercenter in Milford, Delaware. 

The unnamed woman had concealed the weapon, which the MRI machine triggered to fire during an exam.